Sequence and expression pattern of the human MAGE2 gene - PubMed (original) (raw)

Sequence and expression pattern of the human MAGE2 gene

C De Smet et al. Immunogenetics. 1994.

Abstract

We reported previously identification of the human MAGE1 gene, which encodes an antigen recognized on human melanoma MZ2-MEL by autologous cytolytic T lymphocytes. In addition to MAGE1, melanoma MZ2-MEL expresses several closely related genes, one of which has been named MAGE2. The complete MAGE2 sequence was obtained and it comprises 3 exons homologous to those of MAGE1 and an additional exon homologous to a region of the first MAGE1 intron. Like the open reading frame of MAGE1, that of MAGE2 is entirely encoded by the last exon. The MAGE1 and MAGE2 sequences of this exon show 82% identity and the putative proteins show 67% identity. The MAGE2 gene is expressed in a higher proportion of melanoma tumors than MAGE1. It is also expressed in many small-cell lung carcinomas and other lung tumors, laryngeal tumors, and sarcomas. No MAGE1 and MAGE2 gene expression was found in a large panel of healthy adult tissues, with the exception of testis.

PubMed Disclaimer

Similar articles

• Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
  Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T. Gaugler B, et al. J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921. J Exp Med. 1994. PMID: 8113684 Free PMC article.
• A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
  Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. Van den Eynde B, et al. J Exp Med. 1995 Sep 1;182(3):689-98. doi: 10.1084/jem.182.3.689. J Exp Med. 1995. PMID: 7544395 Free PMC article.
• Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.
  De Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora JP, De Backer O, Boon T. De Smet C, et al. Immunogenetics. 1995;42(4):282-90. doi: 10.1007/BF00176446. Immunogenetics. 1995. PMID: 7672823
• BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes.
  Boël P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, van der Bruggen P. Boël P, et al. Immunity. 1995 Feb;2(2):167-75. doi: 10.1016/s1074-7613(95)80053-0. Immunity. 1995. PMID: 7895173
• Tumor antigens recognized by T lymphocytes.
  Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Boon T, et al. Annu Rev Immunol. 1994;12:337-65. doi: 10.1146/annurev.iy.12.040194.002005. Annu Rev Immunol. 1994. PMID: 8011285 Review.

Cited by

• Research progress in effects of MAGE-A family on gastric cancer.
  Jia Q, Xian X, Li Y, Mu J, DU Z. Jia Q, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Feb 28;48(2):260-267. doi: 10.11817/j.issn.1672-7347.2023.220042. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36999473 Free PMC article. Chinese, English.
• Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
  Li B. Li B. Front Immunol. 2022 Oct 21;13:973881. doi: 10.3389/fimmu.2022.973881. eCollection 2022. Front Immunol. 2022. PMID: 36341370 Free PMC article. Review.
• Cancer vaccines: past, present and future; a review article.
  Grimmett E, Al-Share B, Alkassab MB, Zhou RW, Desai A, Rahim MMA, Woldie I. Grimmett E, et al. Discov Oncol. 2022 May 16;13(1):31. doi: 10.1007/s12672-022-00491-4. Discov Oncol. 2022. PMID: 35576080 Free PMC article. Review.
• Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers.
  Pao SC, Chu MT, Hung SI. Pao SC, et al. Pharmaceutics. 2022 Apr 15;14(4):867. doi: 10.3390/pharmaceutics14040867. Pharmaceutics. 2022. PMID: 35456701 Free PMC article. Review.
• Development of Peptide-Based Vaccines for Cancer.
  Abd-Aziz N, Poh CL. Abd-Aziz N, et al. J Oncol. 2022 Mar 15;2022:9749363. doi: 10.1155/2022/9749363. eCollection 2022. J Oncol. 2022. PMID: 35342400 Free PMC article. Review.

References

1. 1. Int J Cancer. 1989 Oct 15;44(4):634-40 - PubMed
2. 1. J Exp Med. 1992 Nov 1;176(5):1453-7 - PubMed
3. 1. Int J Cancer. 1987 Mar 15;39(3):390-6 - PubMed
4. 1. Cell. 1986 Jan 31;44(2):319-28 - PubMed
5. 1. Science. 1991 Dec 13;254(5038):1643-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource